KATASHA FLATT: Open Payments
NPI 1588010185 · MENTOR, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,694 in 144 payments from 16 companies in 2025. Trend: 2023 $2,128 · 2024 $2,470 · 2025 $2,694
Food & beverage: $2,694
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $1,024 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $323 |
| Janssen Biotech, Inc. | 9 | $235 |
| Aimmune Therapeutics, Inc. | 9 | $205 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $202 |
| Phathom Pharmaceuticals, Inc. | 9 | $173 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Ardelyx, Inc. | 5 | $117 |
| Madrigal Pharmaceuticals | 5 | $102 |
| Novo Nordisk Inc | 3 | $71 |
Products named: RINVOQ, TREMFYA, ENTYVIO, ZENPEP, XIFAXAN, SKYRIZI, VOQUEZNA, LINZESS.
Industry payments across OH — which companies pay providers there.
